# Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department

> **NCT00380679** · PHASE2 · UNKNOWN · sponsor: **Louisiana State University Health Sciences Center in New Orleans**

## Conditions studied

- High Risk for Serious Influenza
- High Risk for Pneumonia

## Interventions

- **BIOLOGICAL:** Influenza vaccination
- **BIOLOGICAL:** Pneumococcal polysaccharide vaccination

## Key facts

- **NCT ID:** NCT00380679
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** — (—)
- **Last updated:** 2006-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380679, "Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00380679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*